Varicella-zoster virus

Industry

CPC
C07K14/04

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/04Varicella-zoster virus

Industries

Patents Grantslast 30 patents

Information Patent Grant
Modified cytomegalovirus proteins and stabilized complexes
- Patent number 11,932,669
- Issue date Mar 19, 2024
- GlaxoSmithKline Biologicals SA
- Enrico Malito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression cassette with a SynP160 promoter
- Patent number 11,883,507
- Issue date Jan 30, 2024
- FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
- Dominik Hartl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activin receptor type IIB variants and methods of use thereof
- Patent number 11,884,715
- Issue date Jan 30, 2024
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human cytomegalovirus GB polypeptide
- Patent number 11,857,622
- Issue date Jan 2, 2024
- Pfizer Inc.
- Yuhang Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression system for expressing herpesvirus glycoprotein complexes
- Patent number 11,844,833
- Issue date Dec 19, 2023
- City of Hope
- Felix Wussow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ii vaccine adjuvant
- Patent number 11,813,327
- Issue date Nov 14, 2023
- University of Copenhagen
- Peter Johannes Holst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 11,692,012
- Issue date Jul 4, 2023
- Oregon Health & Science University
- Klaus Frueh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Precision activation of HIV-specific CTLS to eliminate reactivated...
- Patent number 11,407,806
- Issue date Aug 9, 2022
- Albert Einstein College of Medicine
- Harris Goldstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression system for expressing herpesvirus glycoprotein complexes
- Patent number 11,389,529
- Issue date Jul 19, 2022
- City of Hope
- Felix Wussow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 11,266,732
- Issue date Mar 8, 2022
- Oregon Health & Science University
- Louis Picker
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Re-directed immunotherapy
- Patent number 11,236,131
- Issue date Feb 1, 2022
- The University of Birmingham
- Mark Cobbold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ii vaccine adjuvant
- Patent number 11,179,461
- Issue date Nov 23, 2021
- University of Copenhagen
- Peter Johannes Holst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies and peptides to treat HCMV related diseases
- Patent number 11,174,322
- Issue date Nov 16, 2021
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Sophie Alain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 10,995,121
- Issue date May 4, 2021
- Oregon Health & Science University
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitory peptides of viral infection
- Patent number RE47838
- Issue date Feb 4, 2020
- University of Tennessee Research Foundation
- Jonathan S. Wall
Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 10,428,118
- Issue date Oct 1, 2019
- Oregon Health & Science University
- Klaus Frueh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitory peptides of viral infection
- Patent number 10,308,685
- Issue date Jun 4, 2019
- University of Tennessee Research Foundation
- Jonathan S. Wall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 9,982,241
- Issue date May 29, 2018
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitory peptides of viral infection
- Patent number 9,683,017
- Issue date Jun 20, 2017
- UNIVERSITY TENNESSEE RESEARCH FOUNDATION
- Jonathan S. Wall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide compositions and methods for inhibiting herpesvirus infection
- Patent number 9,434,769
- Issue date Sep 6, 2016
- The Administrators of the Tulane Educational Fund
- Lilia I. Melnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 9,249,427
- Issue date Feb 2, 2016
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Patent number 9,180,162
- Issue date Nov 10, 2015
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide compositions and methods for inhibiting herpesvirus infection
- Patent number 8,802,106
- Issue date Aug 12, 2014
- The Administrators of the Tulane Educational Fund
- Lilia I. Melnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T-cell receptor capable of recognising an antigen from cytomegalovirus
- Patent number 8,722,048
- Issue date May 13, 2014
- UCL Business plc
- Hans Stauss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Full genome DNA of human cytomegalovirus strain JHC isolated from K...
- Patent number 8,715,696
- Issue date May 6, 2014
- Mogam Biotechnology Research Institute
- Chan Hee Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Codon-optimized polynucleotide-based vaccines against human Cytomeg...
- Patent number 8,673,317
- Issue date Mar 18, 2014
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Patent number 8,278,093
- Issue date Oct 2, 2012
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Patent number 7,888,112
- Issue date Feb 15, 2011
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Patent number 7,410,795
- Issue date Aug 12, 2008
- Vical Incorporated
- Gary G. Hermanson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED CYTOMEGALOVIRUS PROTEINS AND STABILIZED COMPLEXES
- Publication number 20240383949
- Publication date Nov 21, 2024
- GlaxoSmithKline Biologicals S.A.
- Enrico MALITO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE
- Publication number 20240100153
- Publication date Mar 28, 2024
- Pfizer Inc.
- Yuhang Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOGENIC PEPTIDE
- Publication number 20240058437
- Publication date Feb 22, 2024
- UCL Business LTD
- Matthew Bryan Reeves
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and compositions for eliminating engineered immune cells
- Publication number 20230405047
- Publication date Dec 21, 2023
- Miltenyi Biotec B.V. & Co. KG
- Dominik Lock
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN CYTOMEGALOVIRUS POLYEPITOPE VACCINE COMPOSITION
- Publication number 20230173061
- Publication date Jun 8, 2023
- The Council of the Queensland Institute of Medical Research
- Rajiv Khana
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION SYSTEM FOR EXPRESSING HERPESVIRUS GLYCOPROTEIN COMPLEXES
- Publication number 20230140549
- Publication date May 4, 2023
- CITY OF HOPE
- Felix WUSSOW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE
- Publication number 20220088184
- Publication date Mar 24, 2022
- Pfizer Inc.
- Yuhang Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Human Cytomegalovirus Comprising Exogenous Antigens
- Publication number 20220064225
- Publication date Mar 3, 2022
- Oregon Health & Science University
- Klaus FRUEH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR SCREENING AND IDENTIFYING AGENTS THAT INHIBIT OR MODULA...
- Publication number 20210396761
- Publication date Dec 23, 2021
- AiCuris GmbH & Co. KG
- Manfred MARSCHALL
- G01 - MEASURING TESTING
Information Patent Application
IMMUNE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION TH...
- Publication number 20210290759
- Publication date Sep 23, 2021
- BRAVOVAX CO., LTD
- Ting MU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED CYTOMEGALOVIRUS PROTEINS AND STABILIZED COMPLEXES
- Publication number 20210277067
- Publication date Sep 9, 2021
- GlaxoSmithKline Biologicals S.A.
- Enrico MALITO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRECISION ACTIVATION OF HIV-SPECIFIC CTLS TO ELIMINATE REACTIVATED...
- Publication number 20210107967
- Publication date Apr 15, 2021
- ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Harris Goldstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION SYSTEM FOR EXPRESSING HERPESVIRUS GLYCOPROTEIN COMPLEXES
- Publication number 20200155670
- Publication date May 21, 2020
- CITY OF HOPE
- Felix WUSSOW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Cytomegalovirus Comprising Exogenous Antigens
- Publication number 20200102354
- Publication date Apr 2, 2020
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF
- Publication number 20190099479
- Publication date Apr 4, 2019
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN CYTOMEGALOVIRUS COMPRISING EXOGENOUS ANTIGENS
- Publication number 20180282378
- Publication date Oct 4, 2018
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORY PEPTIDES OF VIRAL INFECTION
- Publication number 20170267722
- Publication date Sep 21, 2017
- University of Tennessee Research Foundation
- Jonathan S. Wall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...
- Publication number 20140186382
- Publication date Jul 3, 2014
- Vical Incorporated
- Gary G. Hermanson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN CYTOMEGALOVIRUS VACCINE
- Publication number 20130164289
- Publication date Jun 27, 2013
- Virginia Commonwealth University
- Michael McVoy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Recombinant HCMV and RHCMV vectors and uses thereof
- Publication number 20130136768
- Publication date May 30, 2013
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T-CELL RECEPTOR CAPABLE OF RECOGNISING AN ANTIGEN FROM CYTOMEGALOVIRUS
- Publication number 20130045221
- Publication date Feb 21, 2013
- UCL BUSINESS PLC
- Hans Stauss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...
- Publication number 20130017217
- Publication date Jan 17, 2013
- Vical Incorporated
- Gary G. Hermanson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING HERPESVIRUS INFECTION
- Publication number 20130005648
- Publication date Jan 3, 2013
- The Administrators of the Tulane Educational Fund
- Lilia I. Melnik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FULL GENOME DNA OF HUMAN CYTOMEGALOVIRUS STRAIN JHC ISOLATED FROM K...
- Publication number 20120237921
- Publication date Sep 20, 2012
- MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE
- Chan Hee LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...
- Publication number 20110177124
- Publication date Jul 21, 2011
- Vical Incorporated
- Gary G. HERMANSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Publication number 20080085870
- Publication date Apr 10, 2008
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Codon-optimized polynucleotide-based vaccines against human cytomeg...
- Publication number 20040209241
- Publication date Oct 21, 2004
- Vical Incorporated
- Gary G. Hermanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Varicella-zoster virus

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Modified cytomegalovirus proteins and stabilized complexes

Expression cassette with a SynP160 promoter

Activin receptor type IIB variants and methods of use thereof

Human cytomegalovirus GB polypeptide

Expression system for expressing herpesvirus glycoprotein complexes

Ii vaccine adjuvant

Human cytomegalovirus comprising exogenous antigens

Precision activation of HIV-specific CTLS to eliminate reactivated...

Expression system for expressing herpesvirus glycoprotein complexes

Recombinant HCMV and RHCMV vectors and uses thereof

Re-directed immunotherapy

Ii vaccine adjuvant

Antibodies and peptides to treat HCMV related diseases

Human cytomegalovirus comprising exogenous antigens

Inhibitory peptides of viral infection

Human cytomegalovirus comprising exogenous antigens

Inhibitory peptides of viral infection

Recombinant HCMV and RHCMV vectors and uses thereof

Inhibitory peptides of viral infection

Peptide compositions and methods for inhibiting herpesvirus infection

Recombinant HCMV and RHCMV vectors and uses thereof

Codon-optimized polynucleotide-based vaccines against human cytomeg...

Peptide compositions and methods for inhibiting herpesvirus infection

T-cell receptor capable of recognising an antigen from cytomegalovirus

Full genome DNA of human cytomegalovirus strain JHC isolated from K...

Codon-optimized polynucleotide-based vaccines against human Cytomeg...

Codon-optimized polynucleotide-based vaccines against human cytomeg...

Codon-optimized polynucleotide-based vaccines against human cytomeg...

Codon-optimized polynucleotide-based vaccines against human cytomeg...

Patents Applicationslast 30 patents

MODIFIED CYTOMEGALOVIRUS PROTEINS AND STABILIZED COMPLEXES

HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE

IMMUNOGENIC PEPTIDE

Methods and compositions for eliminating engineered immune cells

HUMAN CYTOMEGALOVIRUS POLYEPITOPE VACCINE COMPOSITION

EXPRESSION SYSTEM FOR EXPRESSING HERPESVIRUS GLYCOPROTEIN COMPLEXES

HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE

Human Cytomegalovirus Comprising Exogenous Antigens

METHODS FOR SCREENING AND IDENTIFYING AGENTS THAT INHIBIT OR MODULA...

IMMUNE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION TH...

MODIFIED CYTOMEGALOVIRUS PROTEINS AND STABILIZED COMPLEXES

PRECISION ACTIVATION OF HIV-SPECIFIC CTLS TO ELIMINATE REACTIVATED...

EXPRESSION SYSTEM FOR EXPRESSING HERPESVIRUS GLYCOPROTEIN COMPLEXES

Human Cytomegalovirus Comprising Exogenous Antigens

RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF

HUMAN CYTOMEGALOVIRUS COMPRISING EXOGENOUS ANTIGENS

INHIBITORY PEPTIDES OF VIRAL INFECTION

CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...

HUMAN CYTOMEGALOVIRUS VACCINE

Recombinant HCMV and RHCMV vectors and uses thereof

T-CELL RECEPTOR CAPABLE OF RECOGNISING AN ANTIGEN FROM CYTOMEGALOVIRUS

CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...

PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING HERPESVIRUS INFECTION

FULL GENOME DNA OF HUMAN CYTOMEGALOVIRUS STRAIN JHC ISOLATED FROM K...

CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEG...

Codon-optimized polynucleotide-based vaccines against human cytomeg...

Codon-optimized polynucleotide-based vaccines against human cytomeg...